Denver, Colorado - Markets open the session with strategic partnerships, infrastructure consolidation, and breakthrough technologies dominating the corporate news cycle; several companies are positioning themselves at the intersection of innovation and scalable commercialization.
Pediatric Cancer Innovation Advances in Cell Therapy
Clinical-stage biotech MiNK Therapeutics (NASDAQ:INKT) announced a strategic collaboration with the international pediatric oncology consortium C-Further to develop a PRAME-targeted TCR-engineered invariant natural killer T (iNKT) cell therapy aimed at treating pediatric cancers.
The consortium, enabled by Cancer Research Horizons, LifeArc, and Great Ormond Street Hospital Charity, selected MiNK’s program as one of its first supported initiatives. The collaboration includes approximately $1.1 million in non-dilutive funding to advance IND-enabling work and provides the company with a potential double-digit share of downstream commercial revenues.
The therapy targets PRAME (Preferentially Expressed Antigen in Melanoma), a tumor-associated antigen widely expressed across pediatric malignancies such as sarcomas, acute myeloid leukemia, and medulloblastoma. Researchers at the University of Southampton will conduct independent preclinical studies to evaluate tumor activity, persistence, and safety across pediatric cancer models.
MiNK’s approach uses allogeneic off-the-shelf iNKT cells, which can be manufactured in advance and delivered without HLA matching or intensive preconditioning, potentially accelerating treatment timelines for children facing aggressive cancers.
Aviation Infrastructure: VTAK Consolidates Flyte Platform
In transportation infrastructure, Catheter Precision (NYSE:VTAK) announced it has acquired the remaining 80.02% equity interest in Fly Flyte, Inc., giving the company full ownership of the AI-enabled regional aviation operator.
The acquisition converts Flyte from a minority investment into a wholly owned operating subsidiary, allowing VTAK to consolidate revenues and assets from the business. Flyte operates Cirrus Vision Jets under FAA Part 135 certification, targeting high-frequency regional routes where traditional airline service is limited or absent.
The model emphasizes capital-efficient fleet expansion and high aircraft utilization, positioning VTAK to participate in the growing regional mobility market while generating revenue with existing certified aircraft and infrastructure.
Advanced Biomaterials Reach Milestone
Biotechnology innovator Kraig Biocraft Laboratories (OTCQB:KBLB) reported a major milestone in Project Atlas, its next-generation biomaterial engineering initiative designed to create new high-performance fibers for industrial and defense applications.
Project Atlas integrates multiple genetic modifications into a unified architecture, producing new transgenic lines capable of generating enhanced spider silk materials with increased strength and durability.
The program represents a broader push to expand the commercial applications of bioengineered spider silk beyond textiles into high-performance industrial and defense materials, as the company advances its evaluation pipeline for the newly developed lines.
AI Marketing Ecosystem Expands
Marketing technology firm Stagwell (NASDAQ:STGW) unveiled a strategic partnership with mobile advertising platform AppLovin (NASDAQ:APP) to integrate AppLovin’s Axon AI advertising engine into Stagwell’s media offering.
Axon reaches more than one billion users daily across mobile apps and connected TV, leveraging machine learning to optimize campaign performance in real time. Through the partnership, Stagwell clients gain access to the platform’s targeting, measurement, and reporting capabilities, particularly within mobile gaming ecosystems where engagement levels remain high.
The partnership underscores the continued convergence of AI, digital advertising, and real-time data analytics as brands seek measurable performance outcomes in mobile environments.
MedTech Meets Artificial Intelligence
In digital health, HeartBeam (NASDAQ:BEAT) announced a collaboration with the Icahn School of Medicine at Mount Sinai to develop next-generation AI-powered ECG algorithms.
HeartBeam’s patented platform captures the heart’s electrical activity in three non-coplanar dimensions, enabling the generation of synthesized 12-lead ECG data outside traditional clinical settings. By combining that dataset with Mount Sinai’s clinically annotated ECG records, the partnership aims to train AI models capable of detecting cardiovascular risk earlier and enabling personalized monitoring from home.
The collaboration positions HeartBeam to expand from rhythm monitoring into AI-enabled disease detection, predictive cardiology, and chronic condition management.
AI Data Infrastructure Nears Public Listing
Meanwhile, Signing Day Sports (NYSE:SGN) said its previously announced business combination with BlockchAIn Digital Infrastructure is expected to close March 16, 2026, with the combined entity trading on the NYSE American under ticker AIB.
BlockchAIn Digital Infrastructure operates data infrastructure designed for AI workloads, high-performance computing, and accelerated compute applications. The company currently runs a 40-megawatt data center in South Carolina that generated approximately $22.9 million in revenue and $5.7 million in net income in 2024, with additional expansion projects planned for 2026 and 2027.
The listing highlights continued investor interest in AI infrastructure platforms, as demand for compute capacity and data center power accelerates globally.
For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com
About 24/7 Market News
In today's fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you're an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247marketnews.com to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 24/7 is a third-party media provider that owns KBLB shares, which are on deposit and may be sold at the editor’s discretion, and has been compensated for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.
For further information, please visit 247marketnews.com or https://go.247marketnews.com/kblb-disclosure/
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.
